- Poster presentation
- Open Access
Routine cine-CMR for assessment of prosthesis-associated mitral regurgitation - a multicenter, multivendor study
© Simprini et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Pulmonary Vein
- Left Atrium
- Mitral Regurgitation
- Severe Mitral Regurgitation
- Moderate Mitral Regurgitation
Mitral regurgitation (MR) is clinically important for patients with prosthetic mitral valves (PMV). While CMR can quantify MR based on flow, this requires dedicated imaging. Cine-CMR (SSFP) provides an alternative approach, whereby MR can be graded based on regurgitation-associated intervoxel dephasing. As cine-CMR is a standard component of nearly all exams, it could be used to screen for patients who warrant further quantitative imaging. Diagnostic performance of cine-CMR for prosthesis-associated MR has not been evaluated.
Databases at 6 sites were queried for all patients with PMV in whom CMR and echocardiography were performed within 10 days. Cine-CMR images were retrieved and interpreted using a uniform protocol: MR was visually graded based solely on jet size (mild <1/3, moderate 1/3-2/3, severe >2/3) in relation to the left atrium. MR was graded in each long axis plane (2-, 3-, 4-chamber), with overall severity based on mean grade. Additional parameters included jet directionality, signal intensity (3-grade scale), and pulmonary vein flow reversal. Echocardiography (TTE, TEE) was used as a comparator for MR based on clinically reported data. Cine-CMR was interpreted blinded to patient history and TTE/TEE.
56 patients with PMV (70% mechanical, 30% bio) underwent cine-CMR and echo (TTE 70%, TEE 48%) within 2.5±2.6 days. Cine-CMR (1.5T, typical TR=3msec, TE=1msec, BW=977Hz/pixel) was performed using commercial scanners (Siemens 59%/GE 36%/Philips 5%). MR was present on cine-CMR in 77% of patients (mild 43%, moderate 14%, severe 20%), and varied in direction (central 88%, eccentric 12%). Patients with severe MR had higher prevalence of dense regurgitant jets (73% vs. 3%, p<0.001), more frequent pulmonary vein reversal (55% vs. 3%, p<0.001), and larger left atria (5.7±1.0cm vs. 4.7±1.4cm, p=0.03) than did those with lesser MR, but did not differ based on LVEF (53±14% vs. 49±15%, p=0.4). Compared to TEE, cine-CMR yielded excellent diagnostic accuracy (96%) for severe MR (Table); accuracy was also high (93%) when a broader TEE threshold (≥moderate MR) was applied. Among patients with TTE and cine-CMR, no patients had severe MR on TTE missed by cine-CMR, whereas TTE was discordant (lesser MR) in 83% (5/6) with severe MR on cine-CMR. Among those with all three tests (n=10), TEE-evidenced severe MR was diagnosed by TTE in 50% (1/2), whereas cine-CMR diagnosed severe MR in all (2/2) cases.
Cine-CMR diagnostic performance for prosthesis-associated mitral regurgitation
Positive predictive value
Negative predictive value
Substantial (≥moderate) MR
Among a blinded multicenter cohort with PMV, cine-CMR yielded excellent diagnostic performance (accuracy=96%) for TEE-evidenced severe MR. Findings support use of cine-CMR for non-invasive assessment of prosthesis-associated MR.
K23 HL 102249-01.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.